BTG (BTG)

Sector: Pharma and Biotech     Index: FTSE 250
-1.16%
-7.50p
637.50p
17:17 23/05/17
637.50p
17:17 23/05/17
DAILY VARIATION
-1.16%
-7.50p
VOLUME
533,171
REAL TIME BATS
640.00p
17:36 23/05/17
-0.85%
-5.50p
DATA
52 Week High
730.00p
52 Week Low
534.50p
Shares Issued
385.13m
Market Cap
£2,455.19m
RiskGrade
n/a
Beta
0.61
MENU

BTG Overview

BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.

Intraday Chart

Historic Charts

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn 10.1% 22.4%
ROCE 24.7%
Latest F'cast
P/E 27.6 21.1
PEG 5.0 0.5
Pr/Revenue 4.3 3.9
Pr/Book 2.5
Latest F'cast
Revenue 27.5% 14.9%
PBT -45.0% n/a
EPS 5.5% 14.8%
DPS n/a 0.0%

Key Fundamentals

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2013-03-31 233.70 24.10 14.50p 24.6 0.9 27% n/a 0.0%
2014-03-31 290.50 33.30 14.50p 37.4 0.0 n/a n/a 0.0%
2015-03-31 367.80 26.70 15.70p 45.5 5.5 8% n/a 0.0%
2016-03-31 447.50 57.50 21.90p 28.4 0.7 39% n/a 0.0%
2017-03-31 570.50 31.60 23.10p 25.4 4.6 5% n/a 0.0%

Forecast

slide to see more
Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
2018-03-31 630.00 141.27 32.17p 21.1 0.5 39% 0.00p 0.0%
2019-03-31 663.91 178.50 36.72p 18.5 1.3 14% 0.00p 0.0%

Regulatory News

slide to see more
BTG OPTALYSE PE Study 22-May-17 12:00
Additional Listing 17-May-17 10:00
Final Results 16-May-17 07:03

Newspaper Links

slide to see more